{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T22:16:10Z","timestamp":1790115370228,"version":"4.0.1"},"reference-count":127,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2000,8,1]],"date-time":"2000-08-01T00:00:00Z","timestamp":965088000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2000,8]]},"DOI":"10.1067\/mjd.2000.105567","type":"journal-article","created":{"date-parts":[[2002,7,25]],"date-time":"2002-07-25T00:20:13Z","timestamp":1027556413000},"page":"249-259","source":"Crossref","is-referenced-by-count":270,"special_numbering":"P1","title":["Pharmacology of botulinum toxin"],"prefix":"10.1067","volume":"43","author":[{"given":"Wilber","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jill A.","family":"Foster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arlene S.","family":"Rogachefsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1067\/mjd.2000.105567_bib1","first-page":"11","article-title":"Clostridium botulinum neurotoxins, their structures and modes of action","author":"Shone","year":"1986"},{"key":"10.1067\/mjd.2000.105567_bib2","first-page":"1489","article-title":"In vitro characterization of botulinum toxin types A, C, and D action on human tissues: combined electrophysiologic, pharmacologic, and molecular biologic approaches","volume":"280","author":"Coffield","year":"1997","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1067\/mjd.2000.105567_bib3","first-page":"55","article-title":"Botulism: the present status of the disease","volume":"195","author":"Hatheway","year":"1995","journal-title":"Curr Top Microbiol Immunol"},{"key":"10.1067\/mjd.2000.105567_bib4","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1093\/oxfordjournals.aje.a114455","article-title":"The changing epidemiology of adult botulinum in the United States","volume":"124","author":"Macdonald","year":"1986","journal-title":"Am J Epidemiol"},{"key":"10.1067\/mjd.2000.105567_bib5","doi-asserted-by":"crossref","first-page":"221","DOI":"10.7326\/0003-4819-129-3-199808010-00011","article-title":"Botulism in the United States: a clinical and epidemiologic review","volume":"129","author":"Shapiro","year":"1998","journal-title":"Ann Intern Med"},{"key":"10.1067\/mjd.2000.105567_bib6","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1056\/NEJM197311082891904","article-title":"Epidemiologic, clinical, and laboratory aspects of wound botulism","volume":"289","author":"Merson","year":"1973","journal-title":"N Engl J Med"},{"key":"10.1067\/mjd.2000.105567_bib7","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1016\/S0161-6420(80)35127-0","article-title":"Botulinum toxin injection into extraocular muscles as an alternative to strabismus surgery","volume":"87","author":"Scott","year":"1980","journal-title":"Ophthalmology"},{"key":"10.1067\/mjd.2000.105567_bib8","first-page":"734","article-title":"Botulinum toxin injection of eye muscles to correct strabismus","volume":"79","author":"Scott","year":"1981","journal-title":"Trans Am Ophthalmol Soc"},{"key":"10.1067\/mjd.2000.105567_bib9","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1001\/archopht.1985.01050030043017","article-title":"Botulinum A toxin injection as a treatment for blepharospasm","volume":"103","author":"Scott","year":"1985","journal-title":"Arch Ophthalmol"},{"key":"10.1067\/mjd.2000.105567_bib10","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1016\/S0161-6420(88)32977-5","article-title":"Long-term results and complications of botulinum A toxin in the treatment of blepharospasm","volume":"95","author":"Dutton","year":"1988","journal-title":"Ophthalmology"},{"key":"10.1067\/mjd.2000.105567_bib11","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1001\/archopht.1985.01050090057031","article-title":"Hemifacial spasm treated with botulinum A toxin injection","volume":"103","author":"Savino","year":"1985","journal-title":"Arch Ophthalmol"},{"key":"10.1067\/mjd.2000.105567_bib12","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1212\/WNL.45.11.2109","article-title":"Botulinum toxin type B in the treatment of cervical dystonia: a pilot study","volume":"45","author":"Tsui","year":"1995","journal-title":"Neurology"},{"key":"10.1067\/mjd.2000.105567_bib13","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1212\/WNL.39.1.80","article-title":"Controlled trial of botulinum toxin injections in the treatment of spasmodic torticollis","volume":"39","author":"Gelb","year":"1989","journal-title":"Neurology"},{"key":"10.1067\/mjd.2000.105567_bib14","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/BF00839206","article-title":"Treatment of spasmodic torticollis with local injections of botulinum toxin. One-year follow-up in 37 patients","volume":"239","author":"Poewe","year":"1992","journal-title":"J Neurol"},{"key":"10.1067\/mjd.2000.105567_bib15","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1056\/NEJM199503233321203","article-title":"Intrasphincteric botulinum toxin for the treatment of achalasia","volume":"332","author":"Pasricha","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1067\/mjd.2000.105567_bib16","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1097\/00006534-199212000-00004","article-title":"Contralateral injections of botulinum A toxin for the treatment of hemifacial spasm to achieve increased facial symmetry","volume":"90","author":"Borodic","year":"1992","journal-title":"Plast Reconstr Surg"},{"key":"10.1067\/mjd.2000.105567_bib17","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/j.1524-4725.1992.tb03295.x","article-title":"Treatment of glabellar frown lines with C botulinum -A exotoxin","volume":"18","author":"Carruthers","year":"1992","journal-title":"J Dermatol Surg Oncol"},{"key":"10.1067\/mjd.2000.105567_bib18","first-page":"11","article-title":"The use of botulinum toxin to treat glabella frown lines and other facial wrinkles","volume":"7","author":"Carruthers","year":"1994","journal-title":"Cosmet Dermatol"},{"key":"10.1067\/mjd.2000.105567_bib19","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/S0161-6420(96)30644-1","article-title":"The use of botulinum A toxin to ameliorate facial kinetic frown lines","volume":"103","author":"Foster","year":"1996","journal-title":"Ophthalmology"},{"key":"10.1067\/mjd.2000.105567_bib20","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/j.1524-4725.1996.tb00569.x","article-title":"Cosmetic denervation of the muscles of facial expression with botulinum toxin: a dose-response study","volume":"22","author":"Garcia","year":"1996","journal-title":"Dermatol Surg"},{"key":"10.1067\/mjd.2000.105567_bib21","first-page":"325","article-title":"Cosmetic uses of botulinum A exotoxin","volume":"12","author":"Carruthers","year":"1997","journal-title":"Adv Dermatol"},{"key":"10.1067\/mjd.2000.105567_bib22","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1111\/j.1524-4725.1998.tb04099.x","article-title":"Oculoplastic experience with the cosmetic use of botulinum A exotoxin","volume":"24","author":"Edelstein","year":"1998","journal-title":"Dermatol Surg"},{"key":"10.1067\/mjd.2000.105567_bib23","doi-asserted-by":"crossref","first-page":"142","DOI":"10.3109\/08820539809066090","article-title":"Cosmetic indications for botulinum A toxin","volume":"13","author":"Foster","year":"1998","journal-title":"Semin Ophthalmol"},{"key":"10.1067\/mjd.2000.105567_bib24","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1097\/00006534-199902000-00045","article-title":"Nonsurgical treatment of platysmal bands with injection of botulinum toxin A","volume":"103","author":"Kane","year":"1999","journal-title":"Plast Reconstr Surg"},{"key":"10.1067\/mjd.2000.105567_bib25","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1097\/00006534-199902000-00043","article-title":"Botulinum A exotoxin for the management of platysma bands","volume":"103","author":"Matarasso","year":"1999","journal-title":"Plast Reconstr Surg"},{"key":"10.1067\/mjd.2000.105567_bib26","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1001\/archotol.124.3.321","article-title":"Chemical browlift","volume":"124","author":"Frankel","year":"1998","journal-title":"Arch Otolaryngol Head Neck Surg"},{"key":"10.1067\/mjd.2000.105567_bib27","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1016\/S0190-9622(98)70297-X","article-title":"Botulinum toxin in the treatment of palmar hyperhidrosis","volume":"39","author":"Holmes","year":"1998","journal-title":"J Am Acad Dermatol"},{"key":"10.1067\/mjd.2000.105567_bib28","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1111\/j.1524-4725.1998.tb04257.x","article-title":"Botulinum A neurotoxin for axillary hyperhidrosis: no sweat Botox","volume":"24","author":"Glogau","year":"1998","journal-title":"Dermatol Surg"},{"key":"10.1067\/mjd.2000.105567_bib29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1023\/A:1008694726564","article-title":"Neuromuscular transmission and its pharmacological blockade. Part 1: neuromuscular transmission and general aspects of its blockade","volume":"19","author":"Booij","year":"1997","journal-title":"Pharm World Sci"},{"key":"10.1067\/mjd.2000.105567_bib30","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1080\/21548331.1992.11705473","article-title":"Principles of neuromuscular transmission","volume":"27","author":"Martin","year":"1992","journal-title":"Hosp Pract"},{"key":"10.1067\/mjd.2000.105567_bib31","first-page":"143","article-title":"Growth of clostridia and preparation of their neurotoxins","volume":"195","author":"Shone","year":"1995","journal-title":"Curr Top Microbiol Immunol"},{"key":"10.1067\/mjd.2000.105567_bib32","first-page":"239","article-title":"Hemagglutinin binding mediated protection of botulinum neurotoxin from proteolysis","volume":"7","author":"Sharma","year":"1998","journal-title":"J Nat Toxins"},{"key":"10.1067\/mjd.2000.105567_bib33","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0163-7258(96)00091-5","article-title":"Botulinum toxin as a therapeutic agent","volume":"72","author":"Tsui","year":"1996","journal-title":"Pharmacol Ther"},{"key":"10.1067\/mjd.2000.105567_bib34","first-page":"303","article-title":"Molecular biology of clostridial neurotoxins","author":"Niemann","year":"1991"},{"key":"10.1067\/mjd.2000.105567_bib35","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1146\/annurev.pa.26.040186.002235","article-title":"Molecular pharmacology of botulinum toxin and tetanus toxin","volume":"26","author":"Simpson","year":"1986","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1067\/mjd.2000.105567_bib36","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1083\/jcb.103.2.521","article-title":"Interaction of 125I-labeled botulinum neurotoxins with nerve terminals. I: ultrastructural autoradiographic localization and quantitation of distinct membrane acceptors for types A and B on motor nerves","volume":"103","author":"Black","year":"1986","journal-title":"J Cell Biol"},{"key":"10.1067\/mjd.2000.105567_bib37","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1083\/jcb.103.2.535","article-title":"Interaction of 125I-labeled botulinum neurotoxins with nerve terminals. II: autoradiographic evidence for its uptake into motor nerves by acceptor-mediated endocytosis","volume":"103","author":"Black","year":"1986","journal-title":"J Cell Biol"},{"key":"10.1067\/mjd.2000.105567_bib38","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1038\/359832a0","article-title":"Tetanus and botulinum-B neurotoxins block neurotransmitter release by proteolytic cleavage of synaptobrevin","volume":"359","author":"Schiavo","year":"1992","journal-title":"Nature"},{"key":"10.1067\/mjd.2000.105567_bib39","first-page":"215","article-title":"Isolation of synaptotagmin as a receptor for types A and E botulinum neurotoxin and analysis of their comparative binding using a new microtiter plate assay","volume":"7","author":"Li","year":"1998","journal-title":"J Nat Toxins"},{"key":"10.1067\/mjd.2000.105567_bib40","doi-asserted-by":"crossref","first-page":"S146","DOI":"10.1002\/(SICI)1097-4598(1997)6+<146::AID-MUS10>3.0.CO;2-4","article-title":"Botulinum toxin: chemistry, pharmacology, toxicity, and immunology","volume":"6","author":"Brin","year":"1997","journal-title":"Muscle Nerve Suppl"},{"key":"10.1067\/mjd.2000.105567_bib41","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1113\/jphysiol.1962.sp006843","article-title":"Influence of nerve-ending activity and of drugs on the rate of paralysis of rat diaphragm preparations by Cl. botulinum type A toxin","volume":"160","author":"Hughes","year":"1962","journal-title":"J Physiol"},{"key":"10.1067\/mjd.2000.105567_bib42","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1136\/jnnp.48.7.725","article-title":"Reflex path length and clonus frequency [letter]","volume":"48","author":"Nathan","year":"1985","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1067\/mjd.2000.105567_bib43","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/1357-4310(96)84845-3","article-title":"Botulinum neurotoxins: mechanism of action and therapeutic applications","volume":"2","author":"Montecucco","year":"1996","journal-title":"Mol Med Today"},{"key":"10.1067\/mjd.2000.105567_bib44","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1038\/362318a0","article-title":"SNAP receptors implicated in vesicle targeting and fusion","volume":"362","author":"Sollner","year":"1993","journal-title":"Nature"},{"key":"10.1067\/mjd.2000.105567_bib45","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1038\/365104a0","article-title":"Cell biology","volume":"365","author":"Huttner","year":"1993","journal-title":"Snappy exocytoxins. Nature"},{"key":"10.1067\/mjd.2000.105567_bib46","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1542\/peds.68.1.50","article-title":"Potentiation of Clostridium botulinum toxin aminoglycoside antibiotics: clinical and laboratory observations","volume":"68","author":"Santos","year":"1981","journal-title":"Pediatrics"},{"key":"10.1067\/mjd.2000.105567_bib47","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1128\/AEM.48.5.951-955.1984","article-title":"Acute toxicity of aminoglycoside antibiotics as an aid in detecting botulism","volume":"48","author":"Wang","year":"1984","journal-title":"Appl Environ Microbiol"},{"key":"10.1067\/mjd.2000.105567_bib48","first-page":"130","article-title":"Effects of aminoglycoside antibiotics on the neuromuscular junction: Part I","volume":"24","author":"Yamada","year":"1986","journal-title":"Int J Clin Pharmacol Ther Toxicol"},{"key":"10.1067\/mjd.2000.105567_bib49","doi-asserted-by":"crossref","first-page":"3126","DOI":"10.1001\/jama.1989.03420210074019","article-title":"Drug and neurotransmitter receptors: new perspectives with clinical relevance","volume":"261","author":"Snyder","year":"1989","journal-title":"JAMA"},{"key":"10.1067\/mjd.2000.105567_bib50","first-page":"43","article-title":"The interaction between aminoquinolines and presynaptically acting neurotoxins","volume":"222","author":"Simpson","year":"1982","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1067\/mjd.2000.105567_bib51","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1007\/BF03009056","article-title":"Neuromuscular blockade and ventilatory failure after cyclosporine","volume":"39","author":"Kadieva","year":"1992","journal-title":"Can J Anaesth"},{"key":"10.1067\/mjd.2000.105567_bib52","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/S0272-6386(99)70299-4","article-title":"Beneficial effects of calcium channel blockade on acute glomerular hemodynamic changes induced by cyclosporine","volume":"33","author":"Fassi","year":"1999","journal-title":"Am J Kidney Dis"},{"key":"10.1067\/mjd.2000.105567_bib53","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/0090-1229(91)90123-R","article-title":"Autoantibodies in D-penicillamine\u2013induced myasthenia gravis: a comparison with idiopathic myasthenia and rheumatoid arthritis","volume":"58","author":"Morel","year":"1991","journal-title":"Clin Immunol Immunopathol"},{"key":"10.1067\/mjd.2000.105567_bib54","first-page":"266","article-title":"Acetylcholine receptor antibody characteristics in myasthenia gravis. II: patients with penicillamine-induced myasthenia or idiopathic myasthenia of recent onset","volume":"49","author":"Vincent","year":"1982","journal-title":"Clin Exp Immunol"},{"issue":"suppl 3","key":"10.1067\/mjd.2000.105567_bib55","first-page":"114","article-title":"Myasthenia associated with D-penicillamine therapy in rheumatoid arthritis","volume":"70","author":"Bucknall","year":"1977","journal-title":"Proc R Soc Med"},{"key":"10.1067\/mjd.2000.105567_bib56","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1212\/WNL.30.11.1246","article-title":"Penicillamine-associated myasthenia gravis","volume":"30","author":"Albers","year":"1980","journal-title":"Neurology"},{"key":"10.1067\/mjd.2000.105567_bib57","first-page":"80","article-title":"Fine antigenic specificities of antibodies in sera from patients with D-penicillamine\u2013induced myasthenia gravis","volume":"74","author":"Tzartos","year":"1988","journal-title":"Clin Exp Immunol"},{"key":"10.1067\/mjd.2000.105567_bib58","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/S0030-6665(20)32241-6","article-title":"Neuromuscular blocking drugs","volume":"14","author":"Walts","year":"1981","journal-title":"Otolaryngol Clin North Am"},{"key":"10.1067\/mjd.2000.105567_bib59","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/0166-2236(89)90109-4","article-title":"Autoimmunity to the voltage-gated calcium channel underlies the Lambert-Eaton myasthenic syndrome, a paraneoplastic disorder","volume":"12","author":"Vincent","year":"1989","journal-title":"Trends Neurosci"},{"key":"10.1067\/mjd.2000.105567_bib60","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1111\/j.1600-065X.1998.tb01217.x","article-title":"Determinant spreading and immune responses to acetylcholine receptors in myasthenia gravis","volume":"164","author":"Vincent","year":"1998","journal-title":"Immunol Rev"},{"key":"10.1067\/mjd.2000.105567_bib61","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/BF02786398","article-title":"Myasthenia gravis as a prototype autoimmune receptor disease","volume":"16","author":"Hoedemaekers","year":"1997","journal-title":"Immunol Res"},{"key":"10.1067\/mjd.2000.105567_bib62","first-page":"16","article-title":"Kinetic studies on the interaction between botulinum toxin type A and the cholinergic neuromuscular junction","volume":"212","author":"Simpson","year":"1980","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1067\/mjd.2000.105567_bib63","first-page":"155","article-title":"The origin, structure, and pharmacological activity of botulinum toxin","volume":"33","author":"Simpson","year":"1981","journal-title":"Pharmacol Rev"},{"key":"10.1067\/mjd.2000.105567_bib64","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/BF00691980","article-title":"Cytotoxic effects of Adriamycin on mouse hypoglossal neurons following retrograde axonal transport from the tongue","volume":"61","author":"Bigotte","year":"1983","journal-title":"Acta Neuropathol (Berl)"},{"key":"10.1067\/mjd.2000.105567_bib65","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1212\/WNL.34.10.1299","article-title":"Retrograde axoplasmic transport of Adriamycin: an experimental form of motor neuron disease?","volume":"34","author":"Yamamoto","year":"1984","journal-title":"Neurology"},{"key":"10.1067\/mjd.2000.105567_bib66","first-page":"414","article-title":"Effects of intramuscular injection of botulinum toxin and doxorubicin on the survival of abducens motoneurons","volume":"40","author":"Gomez-Ramirez","year":"1999","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1067\/mjd.2000.105567_bib67","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1136\/jnnp.33.1.40","article-title":"Changes in motor innervation and cholinesterase localization induced by botulinum toxin in skeletal muscle of the mouse: differences between fast and slow muscles","volume":"33","author":"Duchen","year":"1970","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1067\/mjd.2000.105567_bib68","first-page":"121","article-title":"Effects of repeated botulinum toxin injections on orbicularis oculi muscle","volume":"12","author":"Borodic","year":"1992","journal-title":"J Clin Neuroophthalmol"},{"key":"10.1067\/mjd.2000.105567_bib69","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1212\/WNL.41.11.1800","article-title":"Botulinum-induced alteration of nerve-muscle interactions in the human orbicularis oculi following treatment for blepharospasm","volume":"41","author":"Alderson","year":"1991","journal-title":"Neurology"},{"key":"10.1067\/mjd.2000.105567_bib70","first-page":"119","article-title":"Pharmacology and histology of the therapeutic application of botulinum toxin","author":"Borodic","year":"1994"},{"key":"10.1067\/mjd.2000.105567_bib71","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1001\/archopht.1991.01080030095046","article-title":"Histologic features of human orbicularis oculi treated with botulinum A toxin","volume":"109","author":"Harris","year":"1991","journal-title":"Arch Ophthalmol"},{"key":"10.1067\/mjd.2000.105567_bib72","first-page":"964","article-title":"Motor nerve sprouting in human orbicularis muscle after botulinum A injection","volume":"31","author":"Holds","year":"1990","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1067\/mjd.2000.105567_bib73","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1002\/mus.880170609","article-title":"Elimination of superfluous neuromuscular junctions in rat calf muscles recovering from botulinum toxin-induced paralysis","volume":"17","author":"Hassan","year":"1994","journal-title":"Muscle Nerve"},{"key":"10.1067\/mjd.2000.105567_bib74","doi-asserted-by":"crossref","first-page":"87S","DOI":"10.1046\/j.1365-2672.1998.0840s187S.x","article-title":"Botulinum neurotoxins: mode of action and detection","volume":"27","author":"Wictome","year":"1998","journal-title":"Soc Appl Bacteriol Symp Ser"},{"key":"10.1067\/mjd.2000.105567_bib75","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1007\/978-1-4613-0361-9_39","article-title":"Detection and identification of Clostridium botulinum neurotoxins","volume":"391","author":"Hatheway","year":"1996","journal-title":"Adv Exp Med Biol"},{"key":"10.1067\/mjd.2000.105567_bib76","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1016\/S0041-0101(96)00180-8","article-title":"Pharmacologic characterization of botulinum toxin for basic science and medicine","volume":"35","author":"Pearce","year":"1997","journal-title":"Toxicon"},{"key":"10.1067\/mjd.2000.105567_bib77","first-page":"541","article-title":"Collaborative study of a method for the detection of Clostridium botulinum and its toxins in foods","volume":"60","author":"Kautter","year":"1976","journal-title":"J Assoc Anal Chem"},{"key":"10.1067\/mjd.2000.105567_bib78","first-page":"96","article-title":"Standardized assay for Clostridium botulinum toxins","volume":"61","author":"Schantz","year":"1978","journal-title":"J Assoc Anal Chem"},{"key":"10.1067\/mjd.2000.105567_bib79","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/0140-6736(90)90263-5","article-title":"Dose standardisation of botulinum toxin [letter]","volume":"335","author":"Schantz","year":"1990","journal-title":"Lancet"},{"key":"10.1067\/mjd.2000.105567_bib80","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1002\/mds.870030409","article-title":"Systemic toxicity of botulinum toxin by intramuscular injection in the monkey","volume":"3","author":"Scott","year":"1988","journal-title":"Mov Disord"},{"key":"10.1067\/mjd.2000.105567_bib81","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1016\/S0140-6736(94)90153-8","article-title":"Dose standardisation of botulinum toxin [letter]","volume":"343","author":"First","year":"1994","journal-title":"Lancet"},{"key":"10.1067\/mjd.2000.105567_bib82","first-page":"169","article-title":"New quality control methods of detecting bacterial toxins in food","author":"Tranter","year":"1987"},{"key":"10.1067\/mjd.2000.105567_bib83","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1128\/AEM.50.1.63-67.1985","article-title":"Monoclonal antibody-based immunoassay for type A Clostridium botulinum toxin is comparable to the mouse bioassay","volume":"50","author":"Shone","year":"1985","journal-title":"Appl Environ Microbiol"},{"key":"10.1067\/mjd.2000.105567_bib84","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.1128\/JCM.31.9.2402-2409.1993","article-title":"Sensitive enzyme-linked immunosorbent assay for detection of Clostridium botulinum neurotoxins A, B, and E using signal amplification via enzyme-linked coagulation assay","volume":"31","author":"Doellgast","year":"1993","journal-title":"J Clin Microbiol"},{"key":"10.1067\/mjd.2000.105567_bib85","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1111\/j.1432-1033.1993.tb18327.x","article-title":"Proteolytic cleavage of synthetic fragments of vesicle-associated membrane protein, isoform-2 by botulinum type B neurotoxin","volume":"217","author":"Shone","year":"1993","journal-title":"Eur J Biochem"},{"key":"10.1067\/mjd.2000.105567_bib86","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1111\/j.1432-1033.1994.tb18855.x","article-title":"Solid-phase synthesis, conformational analysis and in vitro cleavage of synthetic human synaptobrevin II 1-93 by tetanus toxin L chain","volume":"222","author":"Cornille","year":"1994","journal-title":"Eur J Biochem"},{"key":"10.1067\/mjd.2000.105567_bib87","first-page":"143","article-title":"Use of crystalline type A botulinum toxin in medical research","author":"Schantz","year":"1981"},{"key":"10.1067\/mjd.2000.105567_bib88","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1128\/CMR.3.1.66","article-title":"Toxigenic clostridia","volume":"3","author":"Hatheway","year":"1990","journal-title":"Clin Microbiol Rev"},{"key":"10.1067\/mjd.2000.105567_bib89","series-title":"Botox package insert","year":"1995"},{"key":"10.1067\/mjd.2000.105567_bib90","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1002\/mus.880180708","article-title":"Five-year experience in the treatment of focal movement disorders with low-dose Dysport botulinum toxin","volume":"18","author":"Van den Bergh","year":"1995","journal-title":"Muscle Nerve"},{"key":"10.1067\/mjd.2000.105567_bib91","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1111\/j.1524-4725.1998.tb04100.x","article-title":"Botulinum toxin type A for facial rejuvenation: United States and United Kingdom perspectives","volume":"24","author":"Lowe","year":"1998","journal-title":"Dermatol Surg"},{"key":"10.1067\/mjd.2000.105567_bib92","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1136\/jnnp.64.1.6","article-title":"A double blind, randomised, parallel group study to investigate the dose equivalence of Dysport and Botox in the treatment of cervical dystonia","volume":"64","author":"Odergren","year":"1998","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1067\/mjd.2000.105567_bib93","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1136\/jnnp.64.6.751","article-title":"Long term results of botulinum toxin type A (Dysport) in the treatment of hemifacial spasm: a report of 175 cases","volume":"64","author":"Jitpimolmard","year":"1998","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1067\/mjd.2000.105567_bib94","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1111\/j.1524-4725.1998.tb04093.x","article-title":"Understanding botulinum toxin: surgical anatomy of the frown, forehead, and periocular region","volume":"24","author":"Wieder","year":"1998","journal-title":"Dermatol Surg"},{"key":"10.1067\/mjd.2000.105567_bib95","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1002\/hed.2880140108","article-title":"Botulinum A toxin for spasmodic torticollis: multiple vs single injection points per muscle","volume":"14","author":"Borodic","year":"1992","journal-title":"Head Neck"},{"key":"10.1067\/mjd.2000.105567_bib96","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1097\/00002341-199103000-00007","article-title":"Innervation zone of orbicularis oculi muscle and implications for botulinum A toxin therapy","volume":"7","author":"Borodic","year":"1991","journal-title":"Ophthal Plast Reconstr Surg"},{"key":"10.1067\/mjd.2000.105567_bib97","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1111\/j.1524-4725.1998.tb04097.x","article-title":"Clinical indications and injection technique for the cosmetic use of botulinum A exotoxin","volume":"24","author":"Carruthers","year":"1998","journal-title":"Dermatol Surg"},{"key":"10.1067\/mjd.2000.105567_bib98","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1111\/j.1524-4725.1998.tb04102.x","article-title":"Anatomy of the platysma and lip depressor muscles","volume":"24","author":"Hoefflin","year":"1998","journal-title":"Dermatol Surg"},{"key":"10.1067\/mjd.2000.105567_bib99","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S1064-7406(23)00302-4","article-title":"Cosmetic use of botulinum toxin","volume":"6","author":"Foster","year":"1998","journal-title":"Facial Plast Surg Clin North Am"},{"key":"10.1067\/mjd.2000.105567_bib100","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1002\/mds.870090106","article-title":"Histologic assessment of dose-related diffusion and muscle fiber response after therapeutic botulinum A toxin injections","volume":"9","author":"Borodic","year":"1994","journal-title":"Mov Disord"},{"key":"10.1067\/mjd.2000.105567_bib101","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1002\/mus.880160913","article-title":"Quantifying how location and dose of botulinum toxin injections affect muscle paralysis","volume":"16","author":"Shaari","year":"1993","journal-title":"Muscle Nerve"},{"key":"10.1067\/mjd.2000.105567_bib102","first-page":"206","article-title":"Cosmetic uses of botulinum A exotoxin","author":"Carruthers","year":"1998"},{"key":"10.1067\/mjd.2000.105567_bib103","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1111\/j.1524-4725.1998.tb04095.x","article-title":"Botulinum A toxin for glabellar wrinkles: dose and response","volume":"24","author":"Hankins","year":"1998","journal-title":"Dermatol Surg"},{"key":"10.1067\/mjd.2000.105567_bib104","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1177\/019459989310800205","article-title":"Crystalline preparation of botulinum toxin type A (Botox): degradation in potency with storage","volume":"108","author":"Gargland","year":"1993","journal-title":"Otolaryngol Head Neck Surg"},{"key":"10.1067\/mjd.2000.105567_bib105","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1212\/WNL.48.1.249","article-title":"Reconstituted botulinum toxin type A does not lose potency in humans if it is refrozen or refrigerated for 2 weeks before use","volume":"48","author":"Sloop","year":"1997","journal-title":"Neurology"},{"key":"10.1067\/mjd.2000.105567_bib106","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1111\/j.1524-4725.1998.tb04092.x","article-title":"History of the cosmetic use of botulinum A exotoxin","volume":"24","author":"Carruthers","year":"1998","journal-title":"Dermatol Surg"},{"key":"10.1067\/mjd.2000.105567_bib107","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/0002-9394(86)90601-X","article-title":"Absence of antibody production in patients treated with botulinum A toxin","volume":"101","author":"Biglan","year":"1986","journal-title":"Am J Ophthalmol"},{"key":"10.1067\/mjd.2000.105567_bib108","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/0002-9394(88)90016-5","article-title":"Negative antibody response to long-term treatment of facial spasm with botulinum toxin","volume":"105","author":"Gonnering","year":"1988","journal-title":"Am J Ophthalmol"},{"key":"10.1067\/mjd.2000.105567_bib109","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1212\/WNL.45.9.1743","article-title":"Response and immunoresistance to botulinum toxin injections","volume":"45","author":"Jankovic","year":"1995","journal-title":"Neurology"},{"key":"10.1067\/mjd.2000.105567_bib110","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1212\/WNL.43.9.1715","article-title":"Botulinum antibodies in dystonic patients treated with type A botulinum toxin: frequency and significance","volume":"43","author":"Zuber","year":"1993","journal-title":"Neurology"},{"key":"10.1067\/mjd.2000.105567_bib111","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1002\/mds.870090216","article-title":"Development of resistance to botulinum toxin type A in patients with torticollis","volume":"9","author":"Greene","year":"1994","journal-title":"Mov Disord"},{"key":"10.1067\/mjd.2000.105567_bib112","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1093\/infdis\/150.3.407","article-title":"Antitoxin levels in botulism patients treated with trivalent equine botulism antitoxin to toxin types A, B, and E","volume":"150","author":"Hatheway","year":"1984","journal-title":"J Infect Dis"},{"key":"10.1067\/mjd.2000.105567_bib113","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1212\/WNL.50.6.1624","article-title":"Mouse bioassay versus Western blot assay for botulinum toxin antibodies: correlation with clinical response","volume":"50","author":"Hanna","year":"1998","journal-title":"Neurology"},{"key":"10.1067\/mjd.2000.105567_bib114","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1177\/000348949710601204","article-title":"Efficacy of repeated botulinum toxin injections as a function of timing","volume":"106","author":"Inagi","year":"1997","journal-title":"Ann Otol Rhinol Laryngol"},{"key":"10.1067\/mjd.2000.105567_bib115","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0304-3940(97)13448-6","article-title":"Botulinum neurotoxin serotype C: a novel effective botulinum toxin therapy in humans","volume":"224","author":"Eleopra","year":"1997","journal-title":"Neurosci Lett"},{"key":"10.1067\/mjd.2000.105567_bib116","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1136\/jnnp.59.6.601","article-title":"Botulinum toxin F in the treatment of torticollis clinically resistant to botulinum toxin A","volume":"59","author":"Sheean","year":"1995","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1067\/mjd.2000.105567_bib117","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1016\/S0190-9622(96)90016-X","article-title":"Botulinum A exotoxin use in clinical dermatology","volume":"34","author":"Carruthers","year":"1996","journal-title":"J Am Acad Dermatol"},{"key":"10.1067\/mjd.2000.105567_bib118","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1097\/00006534-199404001-00003","article-title":"Aesthetic indications for botulinum toxin injection","volume":"93","author":"Guyuron","year":"1994","journal-title":"Plast Reconstr Surg"},{"key":"10.1067\/mjd.2000.105567_bib119","first-page":"137","article-title":"The use of botulinum A toxin to ameliorate facial dynamic lines","volume":"4","author":"Foster","year":"1996","journal-title":"Int J Aesthet Restor Surg"},{"key":"10.1067\/mjd.2000.105567_bib120","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1002\/mus.880140711","article-title":"Distant effects of locally injected botulinum toxin: a double-blind study of single fiber EMG changes","volume":"14","author":"Lange","year":"1991","journal-title":"Muscle Nerve"},{"key":"10.1067\/mjd.2000.105567_bib121","first-page":"3","article-title":"The site and mechanism of action of botulinum neurotoxin","author":"Coffield","year":"1994"},{"key":"10.1067\/mjd.2000.105567_bib122","doi-asserted-by":"crossref","first-page":"23784","DOI":"10.1016\/S0021-9258(20)80452-9","article-title":"Identification of the nerve terminal targets of botulinum neurotoxin serotypes A, D, and E","volume":"268","author":"Schiavo","year":"1993","journal-title":"J Biol Chem"},{"key":"10.1067\/mjd.2000.105567_bib123","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/j.1749-6632.1994.tb26614.x","article-title":"Tetanus and botulinum neurotoxins are zinc proteases specific for components of the neuroexocytosis apparatus","volume":"710","author":"Schiavo","year":"1994","journal-title":"Ann N Y Acad Sci"},{"key":"10.1067\/mjd.2000.105567_bib124","doi-asserted-by":"crossref","first-page":"7694","DOI":"10.1074\/jbc.271.13.7694","article-title":"Clostridial neurotoxins and substrate proteolysis in intact neurons: botulinum neurotoxin C acts on synaptosomal-associated protein of 25 kd","volume":"271","author":"Williamson","year":"1996","journal-title":"J Biol Chem"},{"key":"10.1067\/mjd.2000.105567_bib125","doi-asserted-by":"crossref","first-page":"4821","DOI":"10.1002\/j.1460-2075.1993.tb06171.x","article-title":"Botulinum neurotoxin C1 blocks neurotransmitter release by means of cleaving HPC-1\/syntaxin","volume":"12","author":"Blasi","year":"1993","journal-title":"Embo J"},{"key":"10.1067\/mjd.2000.105567_bib126","doi-asserted-by":"crossref","first-page":"11516","DOI":"10.1016\/S0021-9258(19)50230-7","article-title":"Botulinum neurotoxin serotype F is a zinc endopeptidase specific for VAMP\/synaptobrevin","volume":"268","author":"Schiavo","year":"1993","journal-title":"J Biol Chem"},{"key":"10.1067\/mjd.2000.105567_bib127","doi-asserted-by":"crossref","first-page":"4688","DOI":"10.1073\/pnas.91.11.4688","article-title":"Synaptobrevin\/vesicle-associated membrane protein (VAMP) of Aplysia californica : structure and proteolysis by tetanus toxin and botulinal neurotoxins type D and F","volume":"91","author":"Yamasaki","year":"1994","journal-title":"Proc Natl Acad Sci U S A"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962200366415?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962200366415?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,12,29]],"date-time":"2023-12-29T19:08:58Z","timestamp":1703876938000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962200366415"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,8]]},"references-count":127,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2000,8]]}},"alternative-id":["S0190962200366415"],"URL":"https:\/\/doi.org\/10.1067\/mjd.2000.105567","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2000,8]]}}}